Selected highlights of the Third Annual Biomarkers Congress: from discovery to validation in the drug development arena.
This report summarises selected presentations that focused on aspects of biomarker discovery and validation, imaging in preclinical and clinical development and biomarkers in clinical drug development, as discussed during the Third Annual Biomarkers Congress held in Manchester, UK on 14 - 15 May 2008. More than 140 delegates attended this event to discuss the application of biomarkers to all facets of the drug development process. The conference consisted of five intensive streams discussing current and future directions in: i) biomarker discovery and validation; ii) molecular diagnostics, data integration, data analysis, modelling and bioinformatics; iii) biomarkers in clinical drug development; iv) biomarker discovery and validation: therapeutic areas; and v) imaging in preclinical and clinical development and safety biomarkers. This review will focus on selected presentations from the first, third and fifth streams.